29 /100
MEDIUM RISK
Score updated Jul 13, 2026

CPIX — Cumberland Pharmaceuticals Inc. Dilution Risk Tracker

Track CPIX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CPIX — Get alerts when the score changes →

As of July 13, 2026, Cumberland Pharmaceuticals Inc. (CPIX) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Cumberland Pharmaceuticals Inc. has a market capitalization of $92.15M, 14.98M shares outstanding, 10 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CPIX.
🔔 Track CPIX — Get forecast alerts →

💹 Market Data

Market Cap$92.15M
Shares Outstanding14.98M
Float8.75M
Cash$11.01M
Debt$10.07M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 2.62M shares
#1 Ikarian Capital, LLC 555.9K shares
#2 Renaissance Technologies, LLC 472.2K shares
#3 Vanguard Group Inc 411.8K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest242.4K
Days to Cover5.1
% of Float2.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
Form 4 INSIDER TRANSACTION Mar 18, 2026
Form 4 INSIDER TRANSACTION Mar 18, 2026
Form 4 INSIDER TRANSACTION Mar 18, 2026
Form 4 INSIDER TRANSACTION Mar 18, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CPIX Shareholders

Cumberland Pharmaceuticals Inc. (CPIX) has a DilutionScore of 29/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CPIX shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CPIX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CPIX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CPIX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CPIX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CPIX
📊 CPIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CPIX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.